作者
Anna‐Lena Scherr,Luisa Nader,Kaiyu Xu,Christin Elßner,Panagiotis Bargiotas,Federico Nichetti,Manuel Mastel,Sarah Fritzsche,Eblina Kelmendi,Nathalie Schmitt,Paula Hoffmeister-Wittmann,Sofia M.E. Weiler,Felix Korell,Thomas Albrecht,Maximilian Schwab,H Isele,Annika Kessler,Jennifer Hüllein,Agnieszka Seretny,Liangtao Ye,Toni Urbanik,Stefan Welte,Anne-Laure Leblond,Christoph E. Heilig,Mohammad Rahbari,Adnan Ali,Suchira Gallage,Bénédicte Lenoir,Nina Wilhelm,Ulrike Gärtner,Simon J. Ogrodnik,Christoph Springfeld,Darjus F. Tschaharganeh,Stefan Fröhling,Thomas Longerich,Henning Schulze‐Bergkamen,Dirk Jäger,Lydia Brandl,Peter Schirmacher,Beate K. Straub,Achim Weber,Enrico N. De Toni,Benjamin Goeppert,Mathias Heikenwälder,René Jackstadt,Stephanie Roessler,Kai Breuhahn,Bruno Köhler
摘要
HCC is the most common primary liver tumor, with an increasing incidence worldwide. HCC is a heterogeneous malignancy and usually develops in a chronically injured liver. The NF-κB signaling network consists of a canonical and a noncanonical branch. Activation of canonical NF-κB in HCC is documented. However, a functional and clinically relevant role of noncanonical NF-κB and its downstream effectors is not established.